B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

Circulation

Volumn 105, Issue 20, 2002, Pages 2392-2397

  Berger, Rudolf ^a   Huelsman, Martin ^a   Strecker, Karin ^a   Bojic, Anja ^a   Moser, Petra ^a   Stanek, Brigitte ^a   Pacher, Richard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Death sudden; Heart failure; Natriuretic peptides; Prognosis

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC DISEASE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; ALPROSTADIL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARRHYTHMIA; ATRIAL NATRIURETIC FACTOR; CARDIOTONIC AGENTS; CHRONIC DISEASE; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ENDOTHELIN-1; ENDOTHELINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037150210     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000016642.15031.34     Document Type: Article

References (35)

1. Prevention of sudden death in heart failure
2. Sudden death prevention in patients with advanced ventricular dysfunction
3. Exploration of the precision of classifying sudden cardiac death: Implications for the interpretation of clinical trials
4. Evidence-based analysis of amiodarone efficacy and safety
5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator studies. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study
6. Multicenter Automatic Defibrillator Implantation Trial. Multicenter Unsustained Tachycardia Trial. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: Lessons learned from MADIT and MUSTT
7. Clinical trials update: The Heart Protection Study. IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH
8. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation
9. Can sudden cardiac death be predicted from the T wave of the ECG? A critical examination of T wave alternans and QT interval dispersion
10. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
11. Prognostic evaluation of neurohumoral plasma levels before and during β-blocker therapy in advanced left ventricular dysfunction
12. Natriuretic peptides in the pathophysiology of congestive heart failure
13. Stretch-induced arrhythmias in the isolated canine ventricle: Evidence for the importance of mechanoelectrical feedback
14. Electrophysiological effects of myocardial stretch and mechanical determinants for stretch-activated arrhythmias
15. Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle
16. Effects of mechanoelectrical feedback: Influence among patients with congestive heart failure
17. Impact of volume loading and load reduction on ventricular refractoriness and conduction properties in canine congestive heart failure
18. Electrophysiological consequences of chronic experimentally induced left ventricular pressure overload
19. Sudden death in heart failure: The role of abnormal repolarization
20. Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophysiology Policy Conference
21. Predictors of total mortality and sudden death in mild to moderate heart failure: Captopril-Digoxin Study Group
22. Nonsustained ventricular tachycardia in severe heart failure: Independent marker of increased mortality due to sudden death
23. Mechanism of death in heart failure: The Vasodilator-Heart Failure Trials
24. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial
25. Ambulatory ventricular arrhythmias among, patients with heart failure do not specifically predict an increased risk of sudden death: PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators
26. The problem of ventricular dysrhythmias and sudden death mortality in heart failure: The impact of current therapy
27. Prognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients
28. Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure
29. Long-term predictors of sudden death and low output death in chronic congestive heart failure secondary to coronary artery disease
30. The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials
31. Biochemical detection of left ventricular systolic dysfunction
32. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
33. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction
34. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure
35. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations